{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:30Z","timestamp":1793059950998,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.berh.2007.12.012","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T16:10:10Z","timestamp":1205251810000},"page":"85-100","source":"Crossref","is-referenced-by-count":150,"title":["Osteogenesis imperfecta"],"prefix":"10.1016","volume":"22","author":[{"given":"Francis H.","family":"Glorieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2007.12.012_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2007.12.012_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.me.43.020192.001413","article-title":"Osteogenesis imperfecta","volume":"43","author":"Byers","year":"1992","journal-title":"Annual Review of Medicine"},{"issue":"Suppl 2","key":"10.1016\/j.berh.2007.12.012_bib4","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1002\/jbmr.5650081311","article-title":"Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies","volume":"8","author":"Prockop","year":"1993","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00291667","article-title":"Homozygous osteogenesis imperfecta unlinked to collagen I\u00a0genes","volume":"78","author":"Aitchison","year":"1988","journal-title":"Human Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jmg.30.6.492","article-title":"Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible","volume":"30","author":"Wallis","year":"1993","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S8756-3282(02)00808-6","article-title":"Osteogenesis imperfecta type VII maps to the short arm of chromosome 3","volume":"31","author":"Labuda","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","article-title":"Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect","volume":"17","author":"Glorieux","year":"2002","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jcp.49.8.627","article-title":"Causes of death in osteogenesis imperfecta","volume":"49","author":"McAllion","year":"1996","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.berh.2007.12.012_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bmj.312.7027.351","article-title":"Life expectancy in osteogenesis imperfecta","volume":"312","author":"Paterson","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2007.12.012_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s003300050521","article-title":"Hyperplastic callus formation in osteogenesis imperfecta: CT\u00a0and MRI findings","volume":"8","author":"Rieker","year":"1998","journal-title":"European Radiology"},{"key":"10.1016\/j.berh.2007.12.012_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s003300050729","article-title":"MRI and CT features of hyperplastic callus in osteogenesis imperfecta tarda","volume":"9","author":"Dobrocky","year":"1999","journal-title":"European Radiology"},{"key":"10.1016\/j.berh.2007.12.012_bib15","first-page":"305","article-title":"Recent findings in classification of osteogenesis imperfecta by means of existing dental symptoms","volume":"65","author":"Petersen","year":"1998","journal-title":"ASDC Journal of Dentistry for Children"},{"key":"10.1016\/j.berh.2007.12.012_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1079-2104(96)80048-5","article-title":"Scanning electron microscopy of teeth in osteogenesis imperfecta type I","volume":"81","author":"Lygidakis","year":"1996","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"key":"10.1016\/j.berh.2007.12.012_bib17","first-page":"30","article-title":"Dental manifestations of osteogenesis imperfecta and abnormalities of collagen I metabolism","volume":"18","author":"Lund","year":"1998","journal-title":"Journal of Craniofacial Genetics and Developmental Biology"},{"key":"10.1016\/j.berh.2007.12.012_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/000163502753509446","article-title":"Dental aberrations in children and adolescents with osteogenesis imperfecta","volume":"60","author":"Malmgren","year":"2002","journal-title":"Acta Odontologica Scandinavica"},{"key":"10.1016\/j.berh.2007.12.012_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/01050398409043042","article-title":"Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients","volume":"13","author":"Pedersen","year":"1984","journal-title":"Scandinavian Audiology"},{"key":"10.1016\/j.berh.2007.12.012_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004310051322","article-title":"Hearing loss in children with osteogenesis imperfecta","volume":"159","author":"Kuurila","year":"2000","journal-title":"European Journal of Pediatrics"},{"key":"10.1016\/j.berh.2007.12.012_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1258\/0022215011907442","article-title":"How common is hearing impairment in osteogenesis imperfecta?","volume":"115","author":"Paterson","year":"2001","journal-title":"The Journal of Laryngology and Otology"},{"key":"10.1016\/j.berh.2007.12.012_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/000348940211101014","article-title":"Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey","volume":"111","author":"Kuurila","year":"2002","journal-title":"The Annals of Otology, Rhinology, and Laryngology"},{"key":"10.1016\/j.berh.2007.12.012_bib23","first-page":"975","article-title":"Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta","volume":"46","author":"Wenstrup","year":"1990","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/301689","volume":"62","author":"Korkko","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jmg.39.6.382","article-title":"Testing for osteogenesis imperfecta in cases of suspected non-accidental\u00a0injury","volume":"39","author":"Marlowe","year":"2002","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<28::AID-AJMG6>3.0.CO;2-N","article-title":"Bruck syndrome (osteogenesis imperfecta with congenital joint contractures): review and report on the first North American case","volume":"70","author":"McPherson","year":"1997","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0004.1985.tb01220.x","article-title":"The ocular form of osteogenesis imperfecta: a new autosomal recessive syndrome","volume":"28","author":"Beighton","year":"1985","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib28","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","article-title":"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype","volume":"11","author":"Cundy","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and juvenile Paget's disease","volume":"347","author":"Whyte","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/34.1.68","article-title":"Idiopathic juvenile osteoporosis: experience of twenty-one patients","volume":"34","author":"Smith","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2007.12.012_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0033-8389(05)70314-6","article-title":"Imaging of child abuse","volume":"39","author":"Nimkin","year":"2001","journal-title":"Radiologic Clinics of North America"},{"key":"10.1016\/j.berh.2007.12.012_bib32","first-page":"797","article-title":"The role of dual energy x-ray absorptiometry in aiding the\u00a0diagnosis of pediatric osteogenesis imperfecta","volume":"27","author":"Moore","year":"1998","journal-title":"The American Journal of Orthopedics"},{"key":"10.1016\/j.berh.2007.12.012_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s001980050167","article-title":"Bone density measurements by computed tomography in osteogenesis imperfecta type I","volume":"9","author":"Miller","year":"1999","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.berh.2007.12.012_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3160001","article-title":"Collagen fibril formation","volume":"316","author":"Kadler","year":"1996","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.berh.2007.12.012_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00008480-200012000-00016","article-title":"Osteogenesis imperfecta: perspectives and opportunities","volume":"12","author":"Byers","year":"2000","journal-title":"Current Opinion in Pediatrics"},{"key":"10.1016\/j.berh.2007.12.012_bib36","first-page":"799","article-title":"Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains","volume":"59","author":"Willing","year":"1996","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI0214841","article-title":"Killing the messenger: new insights into nonsense-mediated mRNA decay","volume":"109","author":"Byers","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2007.12.012_bib38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1098-1004(1998)11:5<395::AID-HUMU7>3.0.CO;2-4","article-title":"Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen","volume":"11","author":"Sarafova","year":"1998","journal-title":"Human Mutation"},{"key":"10.1016\/j.berh.2007.12.012_bib39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1073\/pnas.96.3.1054","article-title":"Defective collagen crosslinking in bone, but not in ligament or in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17","volume":"96","author":"Bank","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.berh.2007.12.012_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mgme.2001.3155","article-title":"G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix","volume":"72","author":"Cabral","year":"2001","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.berh.2007.12.012_bib41","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1074\/jbc.M109048200","article-title":"Procollagen with skipping of alpha 1(I) exon 41 has lower binding affinity for alpha 1(I) C-telopeptide, impaired in vitro fibrillogenesis, and altered fibril morphology","volume":"277","author":"Cabral","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2007.12.012_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/path.1030","article-title":"Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV","volume":"196","author":"Galicka","year":"2002","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.berh.2007.12.012_bib43","doi-asserted-by":"crossref","first-page":"21068","DOI":"10.1074\/jbc.271.35.21068","article-title":"Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix","volume":"271","author":"Mundlos","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2007.12.012_bib44","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jbmr.5650100718","article-title":"Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta","volume":"10","author":"Fedarko","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jbmr.5650110611","article-title":"Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts","volume":"11","author":"Fedarko","year":"1996","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib46","first-page":"6","article-title":"Age-related changes in human bone proteoglycan structure: impact of osteogenesis imperfecta","volume":"6","author":"Grzesik","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.berh.2007.12.012_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","article-title":"CRTAP is required for prolyl 3 hydroxylation and mutations cause recessive osteogenesis imperfecta","volume":"127","author":"Morello","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.berh.2007.12.012_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","article-title":"Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta","volume":"39","author":"Cabral","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002239900600","article-title":"The mineralization density of iliac crest bone from children with osteogenesis imperfecta","volume":"64","author":"Boyde","year":"1999","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.berh.2007.12.012_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0021-9290(97)00088-2","article-title":"Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue","volume":"30","author":"Jepsen","year":"1997","journal-title":"Journal of Biomechanics"},{"key":"10.1016\/j.berh.2007.12.012_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib52","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0003-9993(98)90426-9","article-title":"Osteogenesis imperfecta in childhood: treatment strategies","volume":"79","author":"Engelbert","year":"1998","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1016\/j.berh.2007.12.012_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00009957-200303000-00001","article-title":"Modern approach to children with osteogenesis imperfecta","volume":"12","author":"Zeitlin","year":"2003","journal-title":"Journal of Pediatric Orthopaedics. Part B"},{"key":"10.1016\/j.berh.2007.12.012_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0003-9993(98)90207-6","article-title":"Effects of withdrawal of bracing in matched pairs of children with osteogenesis imperfecta","volume":"79","author":"Gerber","year":"1998","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1016\/j.berh.2007.12.012_bib55","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1302\/0301-620X.80B6.8667","article-title":"Surgical stabilisation of the lower limb in osteogenesis imperfecta using the Sheffield Telescopic Intramedullary Rod System","volume":"80","author":"Wilkinson","year":"1998","journal-title":"The Journal of Bone and Joint Surgery. British Volume"},{"key":"10.1016\/j.berh.2007.12.012_bib56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","article-title":"Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta","volume":"16","author":"Devogelaer","year":"1987","journal-title":"Skeletal Radiology"},{"key":"10.1016\/j.berh.2007.12.012_bib57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/07853890510007386","article-title":"Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?","volume":"37","author":"Rauch","year":"2005","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"Astrom","year":"2002","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.berh.2007.12.012_bib60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bone.2003.11.019","article-title":"Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy","volume":"34","author":"Arikoski","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib63","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","article-title":"The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta","volume":"110","author":"Rauch","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2007.12.012_bib64","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during long-term therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I,\u00a0III and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.berh.2007.12.012_bib65","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1651-2227.2003.tb00577.x","article-title":"Treatment of children with osteogenesis imperfecta in Estonia","volume":"92","author":"Maasalu","year":"2003","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.berh.2007.12.012_bib67","first-page":"S12","article-title":"Alendronate in the treatment of pediatric osteogenesis imperfecta","volume":"19","author":"Glorieux","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib68","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2007.12.012_bib69","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1359\/JBMR.040303","article-title":"Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis","volume":"19","author":"Rauch","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib70","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/mpo.10337","article-title":"Assessment of bone health in children and adolescents with cancer: promises and pitfalls of current techniques","volume":"41","author":"Leonard","year":"2003","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1016\/j.berh.2007.12.012_bib71","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/adc.88.9.795","article-title":"Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls","volume":"88","author":"Fewtrell","year":"2003","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.berh.2007.12.012_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-001-1055-5","article-title":"The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta","volume":"72","author":"Shapiro","year":"2003","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.berh.2007.12.012_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","article-title":"Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy","volume":"91","author":"Rauch","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2007.12.012_bib74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","article-title":"Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism","volume":"88","author":"Rauch","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2007.12.012_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib76","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib77","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","article-title":"Maternal and fetal outcome following long term pamidronate treatment before conception: a report of two cases","volume":"19","author":"Munns","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib78","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation","volume":"91","author":"Rauch","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2007.12.012_bib79","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","article-title":"Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta","volume":"40","author":"Rauch","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib80","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-0028-1093710","article-title":"On an attempt to treat primary and secondary osteoporosis with human growth hormone","volume":"7","author":"Kruse","year":"1975","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.berh.2007.12.012_bib81","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-3476(96)70077-X","article-title":"Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis","volume":"129","author":"Antoniazzi","year":"1996","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.berh.2007.12.012_bib82","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(99)00186-6","article-title":"Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IV","volume":"25","author":"Vieira","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.berh.2007.12.012_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/jbmr.2003.18.2.237","article-title":"Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen","volume":"18","author":"Marini","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2007.12.012_bib84","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.berh.2007.12.012_bib86","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.324.7347.1218","article-title":"Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed","volume":"324","author":"Kuijpers","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2007.12.012_bib87","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI10413","article-title":"Marrow stromal stem cells","volume":"105","author":"Bianco","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2007.12.012_bib88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib89","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.berh.2007.12.012_bib90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/6470","article-title":"Mesenchymal stem cells: no longer second class marrow citizens","volume":"5","author":"Gerson","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib91","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/8326","article-title":"Osteogenesis imperfecta calls for caution","volume":"5","author":"Marini","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib92","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/8528","article-title":"Osteogenesis imperfecta calls for caution","volume":"5","author":"Bishop","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2007.12.012_bib93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.322.7278.63","article-title":"Severe osteogenesis imperfecta: new therapeutic options?","volume":"322","author":"Smith","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2007.12.012_bib94","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/mgme.2000.3039","article-title":"Osteogenesis imperfecta: prospects for molecular therapeutics","volume":"71","author":"Forlino","year":"2000","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.berh.2007.12.012_bib95","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/nar\/28.20.4013","article-title":"Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts","volume":"28","author":"Dawson","year":"2000","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.berh.2007.12.012_bib96","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/108729001753231722","article-title":"Delivery of a hammerhead ribozyme specifically downregulates mutant type I collagen mRNA in a murine model of osteogenesis imperfecta","volume":"11","author":"Toudjarska","year":"2001","journal-title":"Antisense & Nucleic Acid Drug Development"},{"key":"10.1016\/j.berh.2007.12.012_bib97","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/hmg\/11.19.2201","article-title":"Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta","volume":"11","author":"Millington-Ward","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.berh.2007.12.012_bib98","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/418222a","article-title":"The chemical repertoire of natural ribozymes","volume":"418","author":"Doudna","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.berh.2007.12.012_bib99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S8756-3282(01)00590-7","article-title":"Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation","volume":"29","author":"Liu","year":"2001","journal-title":"Bone"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694207001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694207001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:14:53Z","timestamp":1708704893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694207001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1521694207001453"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2007.12.012","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}